Low symptomatic COVID-19 in an elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report

BACKGROUND: Follicular lymphoma is an indolent lymphoma that may progress to a highly aggressive form requiring immunochemotherapy. Most regimens utilize rituximab, an anti-CD20 monoclonal antibody, which may affect the clinical course of novel coronavirus, severe acute respiratory syndrome coronavi...

Descripción completa

Detalles Bibliográficos
Autores principales: Łącki, Stanisław, Wyżgolik, Kinga, Nicze, Michał, Georgiew-Nadziakiewicz, Sylwia, Chudek, Jerzy, Wdowiak, Kamil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223830/
https://www.ncbi.nlm.nih.gov/pubmed/34222459
http://dx.doi.org/10.12998/wjcc.v9.i18.4859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223830/
https://www.ncbi.nlm.nih.gov/pubmed/34222459
http://dx.doi.org/10.12998/wjcc.v9.i18.4859

Ejemplares similares